Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine

MLA

Kayvon Modjarrad, et al. “Preclinical Characterization of the Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine.” Npj Vaccines, vol. 9, no. 1, Nov. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1038/s41541-024-01013-9.

APA

Kayvon Modjarrad, Ye Che, Wei Chen, Huixian Wu, Carla I. Cadima, Alexander Muik, Mohan S. Maddur, Kristin R. Tompkins, Lyndsey T. Martinez, Hui Cai, Minah Ramos, Sonia Mensah, Brittney Cumbia, Larissa Falcao, Andrew P. McKeen, Jeanne S. Chang, Kimberly F. Fennell, Kevin W. Huynh, Thomas J. McLellan, … Kena A. Swanson. (2024). Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine. Npj Vaccines, 9(1), 1–13. https://doi.org/10.1038/s41541-024-01013-9

Chicago

Kayvon Modjarrad, Ye Che, Wei Chen, Huixian Wu, Carla I. Cadima, Alexander Muik, Mohan S. Maddur, et al. 2024. “Preclinical Characterization of the Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine.” Npj Vaccines 9 (1): 1–13. doi:10.1038/s41541-024-01013-9.